Phase Holographic Imaging PHI AB (publ)

F:L5W Germany Medical Devices
Market Cap
$2.82 Million
€2.75 Million EUR
Market Cap Rank
#33387 Global
#3765 in Germany
Share Price
€0.04
Change (1 day)
-10.29%
52-Week Range
€0.04 - €0.05
All Time High
€0.05
About

Phase Holographic Imaging PHI AB (publ), a medical technology company, develops and markets non-invasive time-lapse imaging instruments in Sweden and internationally. The company's products include HoloMonitor, a live cell imaging system; HoloMonitor app Suite for cell imaging software facilitates kinetic live cell tracking and analysis; HoloMonitor M4FL, a system for fluorescence; and HoloMonito… Read more

Phase Holographic Imaging PHI AB (publ) (L5W) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of October 2025: -0.224x

Based on the latest financial reports, Phase Holographic Imaging PHI AB (publ) (L5W) has a cash flow conversion efficiency ratio of -0.224x as of October 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-7.34 Million) by net assets (€32.73 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Phase Holographic Imaging PHI AB (publ) - Cash Flow Conversion Efficiency Trend (2022–2025)

This chart illustrates how Phase Holographic Imaging PHI AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Phase Holographic Imaging PHI AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Phase Holographic Imaging PHI AB (publ) ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Phase Holographic Imaging PHI AB (publ) (2022–2025)

The table below shows the annual cash flow conversion efficiency of Phase Holographic Imaging PHI AB (publ) from 2022 to 2025.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-04-30 €48.74 Million €-18.61 Million -0.382x +88.64%
2024-04-30 €4.99 Million €-16.76 Million -3.360x -193.90%
2023-04-30 €3.73 Million €13.34 Million 3.578x +8376.45%
2022-04-30 €26.98 Million €1.14 Million 0.042x --